*Eimunjeze takes charge in acting capacity
After the expiration of her tenure as Director-General of the National Agency for Food and Drug Administration and Control (NAFAC), Prof Moji Adeyeye, has stepped aside from office, and an acting head appointed for the organisation
Reports say directors of various units and departments have been notified of the appointment of Monica Eimunjeze as the acting Director General for the agency.
The change of guard was reportedly conveyed to the management staff of the agency through a memo referenced as NAFDAC/ADM/SM/075, titled: “Appointment of Acting Director General NAFDAC.”
It reads in part: “The management is in receipt of a letter appointing Dr Monica Eimunjeze as the Acting Director General NAFDAC with effect from 12th November, 2022.
“I am therefore directed to bring this development to you for information and guidance.”
Prof Adeyeye, who was appointed in 2017, ended her renewable first term of office on November 2.
It is, however, not clear why the announcement of her replacement was delayed and if her tenure will be renewed.
The acting D-G studied Pharmacy at the Ahmadu Bello University (ABU), Zaria, and graduated in 1986.
She later bagged a Doctor of Pharmacy (Pharm D) degree from Mercer University, Atlanta Georgia and a Master of Science (MSc) in Biotechnology, Innovation and Regulatory Science from Purdue University.
She is said to have a varied experience in the pharmaceutical sector spanning different areas of practice, having had her industrial exposure with GlaxoSmithKline from 1989 to 1996.
She served the company in various capacities and held different positions including as medical representative, quality control manager, and as regulatory affairs manager.
Until her appointment as the acting director general, Ms Eimunjeze was NAFDAC’s Director of Registration and Regulatory Affairs.
She was said to have previously served as the Technical Assistant to the Director General of NAFDAC and as the Director, Drug Evaluation and Research.